Delivery Order SPE2DB20D2104-SPE2DB25FMYCZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,672.61 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count packages) on August 19, 2025, with completion targeted for August 20, 2025. This firm fixed-price contract, which carries no set-aside designation, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Febuxostat 80 mg tablets (30-count supply) valued at $1,799.27. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery through its Corporate Office division. This award represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,394.19, with an ultimate completion date of August 15, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,551.16 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the companies' long-standing relationship supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,001.53 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,514.92 and an ultimate completion date of August 15, 2025. The contract was competitively awarded without set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,768.65 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued under...
- The Defense Logistics Agency awarded a $1,419.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets in quantities of 30, with an ultimate completion date of September 3, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,273.53 on July 28, 2025, for the supply of Febuxostat 80 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Febuxostat 80 mg tablets (30-count units) with a contract value of $2,965.04. The contract features firm fixed pricing and carries an ultimate completion date of August 26, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYCZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,629.42 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count packages). This firm fixed-price, non-set-aside delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a comprehensive $999,999,999.00 indefinite delivery contract with DLA designated SPE2DX that extends through December 2026. This prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The current delivery order for Febuxostat, a medication used to treat gout, reflects the company's role as a critical vendor in the federal medical procurement supply chain, fulfilling specific pharmaceutical needs through competitively awarded, individually firm-priced delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/18/25 |